Dirk Fluhs
Overview
Explore the profile of Dirk Fluhs including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
23
Citations
76
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Dalbah S, Bechrakis N, Thomasen H, Fluhs D, Rating P, Guberina M, et al.
Klin Monbl Augenheilkd
. 2021 Aug;
238(7):781-787.
PMID: 34376008
Aim: To report our experience with ruthenium-brachytherapy of peripheral capillary haemangioblastomas in patients with von Hippel-Lindau disease. Design: Retrospective case series. Methods: A total of 53 haemangioblastomas, treated with ruthenium-brachytherapy,...
12.
Jabbarli L, Guberina M, Biewald E, Fluhs D, Guberina N, Le Guin C, et al.
Clin Exp Ophthalmol
. 2021 Apr;
49(4):357-367.
PMID: 33866652
Background: Radiation-induced scleral necrosis (RISN) is a rare, but a serious complication of brachytherapy for uveal melanoma. We aimed at analysing the incidence, timing and risk factors associated with development...
13.
Zaragoza F, Eichmann M, Fluhs D, Timmermann B, Brualla L
Ocul Oncol Pathol
. 2020 Oct;
6(5):353-359.
PMID: 33123529
Background/aims: The aim of this work is to compare Monte Carlo simulated absorbed dose distributions obtained from Ru eye plaques, whose heterogeneous emitter distribution is known, with the common homogeneous...
14.
Zaragoza F, Eichmann M, Fluhs D, Wittig A, Sauerwein W, Brualla L
Ocul Oncol Pathol
. 2019 Aug;
5(4):276-283.
PMID: 31367591
Background/aims: Ruthenium plaques are used for the treatment of ocular tumors. The aim of this work is the comparison between simulated absorbed dose distributions tallied in an anthropomorphic phantom, obtained...
15.
Stockel E, Eichmann M, Fluhs D, Sommer H, Biewald E, Bornfeld N, et al.
Ocul Oncol Pathol
. 2018 Oct;
4(2):122-128.
PMID: 30320093
Brachytherapy with Ru eye plaques is the most common treatment modality for small to medium-sized uveal melanomas in Europe. So far, no standardized or widely accepted dose prescription protocol for...
16.
Zaragoza F, Eichmann M, Fluhs D, Sauerwein W, Brualla L
Ocul Oncol Pathol
. 2017 Oct;
3(3):204-209.
PMID: 29071271
Background: The distribution of the emitter substance in Ru eye plaques is usually assumed to be homogeneous for treatment planning purposes. However, this distribution is never homogeneous, and it widely...
17.
Ebenau M, Radeck D, Bambynek M, Sommer H, Fluhs D, Spaan B, et al.
Med Phys
. 2016 Aug;
43(8):4598.
PMID: 27487876
Purpose: Plastic scintillation detectors are promising candidates for the dosimetry of low- to medium-energy photons but quantitative knowledge of their energy response is a prerequisite for their correct use. The...
18.
Fluhs D, Fluhs A, Ebenau M, Eichmann M
Ocul Oncol Pathol
. 2016 May;
2(1):5-12.
PMID: 27171681
Background: Dosimetric measurements in small radiation fields with large gradients, such as eye plaque dosimetry with β or low-energy photon emitters, require dosimetrically almost water-equivalent detectors with volumes of <1...
19.
Biewald E, Lautner H, Gok M, Horstmann G, Sauerwein W, Fluhs D, et al.
Br J Ophthalmol
. 2016 Apr;
101(2):204-208.
PMID: 27121095
Background: To report eye salvaging rate, visual acuity (VA), local recurrences, complications and the potential benefit of adjuvant brachytherapy after endoresection of large uveal melanomas. Methods: 200 patients were included...
20.
Sommer H, Ihrig A, Ebenau M, Fluhs D, Spaan B, Eichmann M
Appl Opt
. 2014 Jun;
53(15):3176-82.
PMID: 24922201
The challenge in rendering integral images is to use as much information preserved by the light field as possible to reconstruct a captured scene in a three-dimensional way. We propose...